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Abstract. 
Adults diagnosed with autism are at significantly increased risk of suicidal thoughts, suicidal 
behaviours and dying by suicide. However, it is unclear whether any validated tools are 
currently available to effectively assess suicidality in autistic adults in research and clinical 
practice. This is crucial for understanding and preventing premature death by suicide in this 
vulnerable group. This two stage systematic review therefore aimed to identify tools used to 
assess suicidality in autistic and general population adults, evaluate these tools for their 
appropriateness and measurement properties, and make recommendations for appropriate 
selection of suicidality assessment tools in research and clinical practice. Three databases 
were searched (PsycInfo, Medline and Web of Knowledge). Four frequently used suicidality 
assessment tools were identified, and subsequently rated for quality of the evidence in 
support of their measurement properties using the COSMIN checklist. Despite studies having 
explored suicidality in autistic adults, none had utilised a validated tool. Overall, there was 
lack of evidence in support of suicidality risk assessments successfully predicting future 
suicide attempts. We recommend adaptations to current suicidality assessment tools and 
priorities for future research, in order to better conceptualise suicidality and its 
measurement in autism. 
Keywords: Autism Spectrum Condition, Autistic, Suicidality, Suicide, Self-harm, 
Measurement properties, COSMIN, Systematic review. 
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Introduction. 
Adults diagnosed with Autism Spectrum Conditions (ASC, hereafter autistic adults) are at 
high risk of experiencing suicidality compared to other clinical groups (Hedley and Uljarević, 
2018; Zahid and Upthegrove, 2017; Cassidy et al, 2014; Segers and Rawana, 2014; Hannon 
and Taylor, 2013). Up to 66% of newly diagnosed adults with Asperger Syndrome (ASC 
without language delay or intellectual disability) reported having contemplated suicide, 
significantly higher than the UK general population (17%); and 35% reported that they had 
planned or attempted suicide (Cassidy et al. 2014). In a recent large-scale population study 
in Sweden, those diagnosed with ASC, without co-occurring ID, were at high risk of dying by 
suicide compared to the general population (Hirvikoski et al. 2016). However, there are very 
few studies exploring suicidality in ASC, with no known measures or models yet validated for 
this group (Cassidy and Rodgers, 2017). Clearly, it is crucial to effectively assess suicidality in 
autistic adults. However, it is unclear if there are valid tools available to assess suicidality in 
autistic adults, or whether existing tools need to be adapted for this group.  
 ASC is characterised by difficulties in socialisation, imagination, communication, 
narrow obsessive interests, and sensory difficulties (APA, 2013). A number of characteristics 
of ASC may present challenges for clinicians in accurate identification of suicidality in this 
group. Self-injurious behaviour is commonly associated with ASC, particularly in the context 
of challenging behaviour, repetitive behaviours and co-occurring intellectual disability (ID) 
(see Matson et al. 2007 for a review). However, there is only one study on non-suicidal self-
injury (NSSI) in autistic adults (Maddox et al. 2017). No research has yet explored whether 
autistic people who present with self-injurious behaviours may be experiencing suicidality or 
NSSI (Hannon and Taylor, 2013). This could therefore increase risk of such behaviours being 
inaccurately attributed to autism (termed diagnostic overshadowing), with suicidality not 
necessarily being considered. 
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Other characteristics of ASC may also affect the utility of current tools, which were 
designed for non-autistic populations, to accurately detect suicidality in this group. For 
example, many autistic people tend to interpret information literally (Happe et al. 1995), and 
experience difficulties in ability to recall what has happened to them in the past, and 
imagine what may happen to them in the future (Crane, Lind and Bowler, 2013; Lind and 
Bowler, 2010). These difficulties could affect the ability to answer questions about lifetime 
suicidality, or future suicidal intent (e.g. “How likely are you to attempt suicide someday?” 
Suicidal Behaviour Questionnaire – Revised, Osman et al. 2001). Many autistic people also 
experience difficulty articulating their own internal emotional experiences (termed 
alexythymia, Bird et al. 2010), which may present difficulties when self-reporting on internal 
emotional distress in mental health and suicidality assessments (Cassidy et al. 2018; Cassidy 
et al. 2014).  
There may also be unique aspects of suicidality in ASC which may not be captured in 
traditional tools designed for other populations. For example, many suicide risk assessments 
enquire about communication of suicide intent to others, which is taken to indicate 
increased suicide risk in the general population. However, difficulties in communication, and 
increased chance of being isolated both in terms of access to health services (Raja, 2014) 
and social connections (Orsmond, Shattuck, Cooper, Sterzing, & Anderson, 2013) among 
autistic people, may lead to lower endorsement of such items while not necessarily 
indicating reduced suicide risk. Social isolation and loneliness in autistic people and people 
with high autistic traits increase risk of suicidality (Pelton and Cassidy, 2017; Hedley et al. 
2018), as does lack of tangible social support (Hedley et al. 2017). Therefore it is important 
for clinicians as part of suicidality assessments to probe for social isolation, loneliness and 
support needs in autistic people. Checking understanding of questions in suicidality 
assessments, why the person may not have told others about their suicidality (e.g. I had no 
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one to tell, I did not consider it important etc.), could also reveal important information 
regarding risk level.  
 Given that the presentation of suicidality and cognitive characteristics of ASC may 
impede effective suicide risk assessment using traditional tools, it is crucial to identify what 
suicide risk assessments have been utilised in this group, and if none are available, to 
identify the most robust candidate tools in the general population to adapt. There is a 
growing body of systematic reviews showing a paucity of research exploring the 
measurement properties of outcome measures in ASC, which have made important 
recommendations to improve research and clinical assessment (Cassidy et al. 2018; Hanratty 
et al. 2015; Wigham and McConachie, 2014; McConachie et al. 2015). These reviews have 
used a validated research tool developed to assess the methodological quality of studies 
assessing the measurement properties of health outcome assessment tools: the consensus 
based standards for the selection of health measurement instruments (COSMIN) (Mokkink et 
al. 2016; Mokkink et al. 2012; Mokkink et al. 2010). The COSMIN method involves two 
stages. First, tools used to assess a health outcome in a well-defined population are 
identified from a systematic search of the literature. Subsequently, the tools used frequently 
(at least twice), with evidence of validity (i.e. with reference to a previously published study), 
are searched for using a comprehensive search tool validated for this purpose (Terwee et al. 
2009). The quality of the available evidence is subsequently rated using the COSMIN 
checklist (Mokkink et al. 2016).  
 It is important to note that tools are not either valid or invalid, but are rather valid for 
certain purposes or circumstances (Kamphaus & Frick, 2005). The COSMIN checklist allows a 
systematic assessment of the quality of evidence for and against a range of measurement 
properties, pooled across studies, thus providing a picture of the strengths and weaknesses 
of the most frequently used tools in different contexts. This allows us to make evidence 
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based recommendations on which tools to select for particular clinical and/or research 
contexts. We therefore utilise this robust method to identify suicidality assessment tools 
used in autistic and general population adults, with similar age and intellectual ability, in 
order to draw conclusions about the relative quality of the evidence in each group regarding 
the measurement properties of these tools. Given that autistic adults have difficulty 
accessing psychiatric services due to lack of expertise and service provision for mental health 
in autism (Crane et al. 2018; Raja, 2014), suicidality assessment tools used in screening the 
general population in research and clinical practice will be particularly useful to adapt for 
autistic adults. The current study thus focused on identifying suicidality screening tools used 
in general population screening studies, as opposed to tools primarily used in psychiatric 
groups. From this synthesis of the available evidence, we subsequently make 
recommendations for future research and clinical practice aiming to effectively assess 
suicidality in autistic and non-autistic adults. Given the higher risk of death by suicide in 
autistic adults, without ID (Hirvikoski et al. 2016), we focused the search on adults without 
ID.  
Review Methods: Stage 1 
The protocol for this review is registered within the International Register of Systematic 
Reviews (Registration number: CRD42016035217), and can be accessed online 
(http://www.crd.york.ac.uk/PROSPERO/prospero.asp). This systematic review follows the 
guidelines for Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) standards (Moher et al. 2015). 
Search Strategy 
The following electronic bibliographic databases were searched: Medline, Psychinfo and 
Web of Knowledge. The Cochrane library was also searched to confirm that no other 
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systematic reviews of the current study topic existed. There were two searches carried out 
in stage one for suicidality measures used in; a) autistic adults, without co-occurring ID; and 
b) general population adults, without any co-occurring conditions or ID. The terms for each 
search strategy are included in table 1. The searches were restricted to peer reviewed 
articles published in the English language, between 1992 and 22nd January 2018 – when the 
last searches were run. The current study focused on literature pertaining to ASC without co-
occurring ID, which is frequently referred to as Asperger Syndrome (AS). AS was first 
included as a separate diagnosis in the WHO International Classification of Diseases in 1992, 
so we focused on studies published after this date, when we expected reference to AS to be 
more consistent in the literature. 
INSERT TABLE 1 HERE 
Selection Criteria 
We utilised a standardised approach to the selection of studies as in previous COSMIN 
reviews (e.g. Cassidy et al. 2018). We focused on tools that include more specific (i.e. 
specifically suicidality as opposed to self-harm or non-suicidal self-injury), and broader 
(including in depth assessment of suicidality to help gauge risk level) conceptualisations of 
suicidality than is feasible in single items or subscales. These typically fail to distinguish 
broader conceptualisations of self-harm from suicidal intent, and lack information on 
important risk indicators, such as current and lifetime experience, frequency, intensity, 
intent and access to means. Therefore studies had to focus on a tool specifically assessing 
suicidality, including assessment of suicidal intent (as opposed to self-harm more generally), 
clinically defined as in the International Classification of Diseases (ICD-10), and Diagnostic 
and Statistical Manual of Mental Disorders (DSM-5). Studies which utilised tools with a single 
suicide related question, item or subscale contained within a larger measure (e.g. Mini-
International Neuropsychiatric Interview (MINI) (Hergueta et al. 1998), Structured Clinical 
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Interview for DSM-IV (SCID-II) (First et al. 1997)), and/or without evidence of validity (i.e. by 
reference to a previously published study), were excluded. This is necessary to maximise the 
probability of identified tools having evidence regarding their measurement properties in 
search two.  
 We searched for studies utilising tools to assess both prevalence of suicidality 
(epidemiological/population studies), and assess outcomes (treatment/intervention and 
longitudinal/cohort studies). To be included studies had to focus on adults aged 18 years and 
over, without ID. Where the age range was partly outside this, studies were included if 50% 
or more of the total population studied was over 18 years, and the mean age of the sample 
was 18 years or above. This ensured that the tools were likely to be appropriate for adults. 
We excluded articles using tools which had been adapted specifically for another population 
than ASC or the general population (e.g. for older adults, a particular gender, or a specific 
culture). This was to ensure that the tool would likely be useful for assessing suicidality in 
general population adults, as opposed to a specific sub-group of the general population. We 
included studies using the most up to date version of the tool available, as this is most likely 
to be used in future research and clinical practice. 
General population adult search criteria: Studies were included if data from general 
population adults, without ID or co-occurring conditions, were presented separately, and 
comprised at least 50% of the total sample. Any studies including an autistic comparison 
group were excluded and considered for inclusion in the ASC search.  
Autistic adults search criteria: Studies were included if data from autistic adults were 
presented separately, and if 50% or more of the participants had a diagnosis of ASC.  
 One reviewer (SC) screened the titles and abstracts of articles for inclusion, and where 
there was any doubt on whether an article should be carried over to the full text sift, it was 
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included. SC then conducted the full text sift of articles, with any ambiguous papers 
discussed with LB, EB and JR to reach consensus. All references of included articles were also 
searched for additional articles to include. 
Data Extraction 
Data extraction was performed by SC, and 20% of articles independently checked by LB. A 
data extraction form was adapted from a previously developed form used in similar research 
(Cassidy et al. 2018; Wigham and McConachie, 2014). Data pertaining to: participant 
characteristics, tools used, domains captured and study type, were recorded. 
Results: Stage 1 
ASC  
The search for studies using tools to assess suicidality in autistic adults, identified 672 
articles which were screened, none of which were retained for analysis (Figure 1). A majority 
of the studies initially screened and excluded in the ASC search had explored self-injury and 
challenging behaviour in autistic adults, often with co-occurring ID, as opposed to suicidality 
– i.e. including intent to end one’s own life. Crucially although a limited number of studies 
had explored suicidality in autistic adults, none had used a validated tool designed to assess 
suicidality specifically. A majority of studies in both groups searches had utilised a single 
item designed for the specific study with no evidence of validity, or a single item or subscale 
contained within a larger mental health (MINI, SCID) or depression (e.g. PHQ-9, BDI) 
measure. As stated above, the current study focused specific and broader conceptualisations 
of suicidality than is possible in single items or subscales. Additionally, it is vital that there is 
evidence of validity of tools (e.g. by reference to a previous study) in the first stage, in order 
to identify tools which are likely to meet COSMIN inclusion criteria in the second stage. 
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Hence, no studies of suicidality in ASC were identified which have used a suicidality 
assessment tool with evidence of validity to consider further in stage two. 
General Population  
The search for studies using tools to assess suicidality in general population adults identified 
1,774 articles which were screened, with 25 retained for analysis (Figure 1). Fourteen 
different tools were used to assess suicidality in the studies (Appendix A). Self-report 
questionnaires included: Columbia Suicide Severity Rating Scale (C-SSRS) (Posner et al. 
2011), Measure of Episodic Planning of Suicide (MEPOS) (Anestis et al. 2014), Suicide 
Behaviours Questionnaire Revised (SBQ-R) (Osman et al. 2001), Beck Scale for Suicidal 
Ideation (BSS) (Beck, Steer, and Ranieri, 1988), Beck Suicide Intent Inventory (BSI) (Beck, 
Schuyler and Herman, 1974), Depression Severity Index – Suicide Subscale (DSI-SS) (Metalsky 
and Joiner, 1997), Modified Scale for Suicidal Ideation (MSSI) (Miller et al. 1986), Paykel 
(Paykel et al. 1974), Sheehan Suicidality Tracking Scale (S-STS) (Coric et al. 2009), Suicide 
Assessment Scale (SUAS-S) (Stanley, Träskman-Bendz, and Stanley, 1986), Suicide Ideation 
Scale (SIS) (Rudd, 1989), Suicide Score Scale (SSS) (Innamorati et al. 2008), and the Plutchik 
Suicide Risk Scale (PSRS) (Aradilla-Herrero et al. 2014).  The searches also identified clinician 
interview versions of the Columbia Suicide Severity Rating Scale (C-SSRS) (Posner et al. 
2011), Beck Suicide Intent Inventory (BSI) (Beck, Schuyler, and Herman, 1974), Paykel (Paykel 
et al. 1974), Sheehan Suicidality Tracking Scale (S-STS) (Coric et al. 2009), and the Self-
Injurious Thoughts and Behaviours Interview (SITBI) (Nock et al. 2007). Eight of these tools 
had each only been used in one study in the general population, without co-morbid 
conditions (MEPOS; BSI; DSI-SS; MSSI; S-STS; SUAS-S; SIS; and SSS). Therefore these tools 
were not considered further, as we were interested in tools which had been used frequently 
(at least twice) in the general population with some evidence of validity, to maximise the 
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chances of there being evidence available to evaluate using the COSMIN checklist. Hence, 
four tools (C-SSRS; SBQ-R; BSS; and Paykel) were considered further in stage 2. 
INSERT FIGURE 1 HERE 
Review Methods: Stage 2 
The second stage of the review searched for evidence of the measurement properties of the 
tools identified in stage 1. In order to do this, a comprehensive search was carried out using 
a methodological filter in PubMed, designed to search for studies assessing the 
measurement properties of health outcome assessment tools (Terwee et al. 2009). We 
focused on studies which had explored the measurement properties of the tools in adults 
(18 years and over), without co-occurring ID. Unlike in stage 1, Adult samples with co-
occurring conditions were included, as studies exploring the validity of suicidality assessment 
tools in the general population may nevertheless be validated in psychiatric samples. 
Including studies of clinical samples thus provides useful information regarding the contexts 
the tools may be most useful in research and/or clinical practice. 
Data extraction method 
Once articles were identified from the search, the methodological quality of each article was 
assessed using the COSMIN checklist (Consensus based Standards for the selection of health 
based measurement Instruments) (Monkkink et al. 2016). COSMIN rates the evidence in 
support of 9 measurement properties on a 4-point scale (from excellent to poor): internal 
consistency, reliability, measurement error, content validity, structural validity, hypothesis 
testing, criterion validity, responsiveness to change, and cross cultural validity. COSMIN 
implements a ‘worst score counts’ method, by which an overall rating is assigned to each 
measurement property based on the lowest score provided. For example, if a study is rated 
excellent on all criteria related to internal consistency (e.g. Cohen’s Kappa was calculated, an 
 Measurement properties of suicidality tools 
 12 
adequate sample size was utilised etc.), but the study failed to check the uni-dimensionality 
of the scale, then this study would still be rated as ‘poor’ overall (Monkkink et al. 2010).  
The checklists were completed by SC, with 9 (34.6%) of the articles independently 
rated by SW, both of whom were trained and experienced in using COSMIN. Inter-rater 
reliability between SC and SW was 73%, similar to previous studies (e.g. Cassidy et al. 2018; 
Wigham and McConachie, 2014). Disagreements were resolved with discussion and these 
agreed COSMIN ratings were utilised in the subsequent evidence synthesis. 
Evidence Synthesis 
The quality of the evidence in support of each measurement property needs to be 
considered in the context of the studies’ findings, in order to gauge the amount of evidence 
available for or against each measurement property. First, the quantitative findings from 
each study are given a rating of positive (in support of the property), indeterminate (not 
possible to deduce whether the evidence is for or against the property), or negative 
(evidence against the property). For example, criterion validity is considered positive when 
the study supplies convincing evidence that the criterion used is indeed a gold standard, and 
the correlation between the outcome measure and the gold standard criterion is greater 
than 0.7 (De Vet et al. 2011). Subsequently, the quality of the evidence is considered in the 
context of the studies quantitative findings. Strong evidence (+++/---) is defined as one 
methodologically excellent or several good studies which find consistent evidence for or 
against a measurement property; moderate evidence (++/--)  is defined as one 
methodologically good or several fair studies which find consistent evidence for or against a 
measurement property; limited evidence (+/-) is defined as one methodologically fair study 
finding evidence for or against a measurement property; conflicting evidence (+/-) is where 
the evidence for or against a measurement property is not consistent between studies; and 
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indeterminate evidence (?), is where there are only studies of poor methodological quality 
available for a measurement property (Monkkink et al. 2012). 
INSERT FIGURE 2 HERE 
Results: Stage 2 
The PubMed search for studies assessing the measurement properties of suicidality tools 
used in general population adults identified 218 articles which were screened, 26 of which 
were retained for analysis (figure 2) (see Appendix B for characteristics of the study 
populations included in the analysis). 
 No articles assessing the measurement properties of the Paykel were identified from 
the search. The methodological quality of the included studies are presented in Table 2 and 
the collated evidence pertaining to the measurement properties for each tool are presented 
in Table 3. Many of the articles reported data on differences in scores and normative data, 
which are important for interpretability (De Vet et al. 2011). However, no studies reported 
minimal important change or floor or ceiling effects. 
 INSERT TABLES 2-3 HERE
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Suicide Behaviour Questionnaire – Revised (SBQ-R) Despite evidence of being widely 
used in general population studies of suicidality, only two studies were found assessing the 
measurement properties of the SBQ-R in adults. The quality of the evidence in support of 
hypothesis testing was weak, with one fair study showing significant differences between 
psychiatric and non-clinical populations in line with hypotheses with large effect (Osman et 
al. 2001). The quality of the evidence in support of criterion validity was moderate: 
sensitivity (>.882) and specificity (>.875) were acceptable for successfully differentiating 
suicidal from non-suicidal individuals, using both the first item of the SBQ-R (Aloba et al. 
2017) and total scores (Osman et al. 2001; Aloba et al. 2017). The quality of the evidence for 
internal consistency was strong, with one excellent study showing acceptable Cronbachs 
alpha (.8) for the whole scale, confirmed as unidimensional via factor analysis (Aloba et al. 
2017). Evidence for structural validity was also strong, with one excellent study showing 
support for a one-factor solution (Aloba et al. 2017). 
Beck Scale for Suicide Ideation (BSS) The measurement properties of the BSS have 
primarily been assessed in psychiatric patient samples, despite being used in many general 
population studies. The evidence in support of hypothesis testing was mixed. One study 
showed weak evidence against the BSS predicting future adverse events (e.g. future suicide 
attempts) (de Beurs, Fokkema and O’Connor, 2016), and one poor study (Cochrane-Brink et 
al. 2000, due to the small sample size) showed evidence in support of the BSS predicting 
future adverse events. However, there was moderate evidence for the BSS significantly 
correlating with other relevant measures and demographics (Esfahani, Hashemi and Alavi 
2015; Horon et al. 2012; Kliem et al. 2017; Cochrane-Brink et al. 2000), moderate evidence 
for factors remaining consistent over time (de Beurs et al. 2015), and strong evidence for the 
BSS distinguishing subgroups (e.g. suicide attempters vs. non-attempters) (Horon et al. 2012; 
Healy et al. 2006; Pinninti et al. 2002).   
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The evidence in support of criterion validity for the BSS was similarly mixed. One 
excellent study (de Beurs et al. 2016) showed low specificity (.2) but high sensitivity (.95) for 
the BSS predicting future suicidal behaviour, a good study (Chang and Tan, 2015) showed a 
poor AUC (<.44) for predicting future adverse events and a poor study (due to small sample 
size) showed excellent sensitivity (100%) and specificity (90%) for predicting future 
hospitalisations (Cochran-Brink et al. 2000). However, there was consistent strong evidence 
for high sensitivity and specificity when distinguishing clinical groups (Horon et al. 2012; 
Pinninti et al. 2002; Cochrane-Brink et al. 2002) (e.g. hospitalised vs. non-hospitalised; 
multiple, single or no previous suicide attempts).  
The evidence in support of internal consistency for the BSS was strong, with one 
excellent study showing high internal consistency in a translated version of the BSS (Esfahani 
et al. 2015). Evidence in support of reliability of the BSS was indeterminate, with two studies 
of poor methodological quality - observations were not independent (Healy et al. 2006), or 
sample size was small with patients undergoing treatment between measurements (Pinninti 
et al. 2002). The evidence in support of structural validity for the BSS was strong with factor 
analysis supporting a one-factor solution (Esfahani et al. 2015; Steer et al. 1993; de Beurs et 
al. 2015). One study assessed cross-cultural validity of the BSS in a Tehran sample, but did 
not perform cognitive interviews. However the quality of the translation was fair (with one 
back and forward translation), giving overall weak evidence in support of the BSS cross-
cultural validity (Esfahani et al. 2015). 
Columbia Suicide Severity Rating Scale (C-SSRS) Most studies of the C-SSRS explored 
the measurement properties of the clinician interview version (7/11 studies). There was 
mixed evidence for internal consistency: two studies showed high Cronbach’s alpha for the 
whole measure (Madan et al. 2016, Posner et al. 2011), but not on some subscales (Madan 
et al. 2016), and another study showed a poor alpha (Al-Halabi et al. 2016). There was mixed 
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evidence for reliability: one excellent study showed a large range of inter-rater reliability (r = 
.5 - .9) (Youngstrom et al. 2016), but two poor studies with small samples showed high 
agreement between raters (.9+) (Hesdorffer et al. 2013; Mundt et al. 2010). The evidence in 
support of structural validity was strong (Madan et al. 2016), as was the evidence in support 
of hypothesis testing and criterion validity (Madan et al. 2016; Al-Halabi et al. 2016; Horwitz, 
Czyz and King, 2015; Hesdorffer et al. 2013; Mundt et al. 2010; Posner et al. 2011). It is also 
important to note that one of these studies rated as ‘good’, showed that the C-SSRS had 
acceptable specificity and sensitivity (>.7) for predicting future adverse events 6 months 
after discharge (Madan et al. 2016). Evidence for responsivity to change was moderate, with 
two fair studies (Al-Halabi et al. 2016; Posner et al. 2011).One good study found moderate 
evidence in support of cross-cultural validity, but cognitive interviews were not conducted 
(Al-Halabi et al. 2016). 
Four studies explored the measurement properties of the C-SSRS self-report version. 
There was weak evidence against hypothesis testing, with one fair study showing a poor 
correlation with the S-STS (Sheehan et al. 2014). There was mixed evidence for criterion 
validity: one good study showed high specificity and sensitivity with clinical assessment 
(Yiguera et al. 2015); one fair study showed evidence against the measure with poor 
agreement with the S-STS (25), and another good study showed evidence against the 
measure with poor prediction of future adverse events (Chang and Tan, 2015).  
Self-Injurious Thoughts and Behaviours Interview (SITBI) One study had explored 
measurement properties of the translated Spanish version of the SITBI in 150 inpatients 
(Garcia-Nieto et al. 2013). Evidence for reliability was mixed. Evidence for inter-rater 
reliability was poor given the small subsample in which this was assessed (n=15), but in 
support of the measure with near perfect agreement between raters (k = .09 – 1). Evidence 
for test retest reliability was fair, but against the measure with poor reliability for suicidal 
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gestures and self-harm. Evidence for hypothesis testing was fair, but against the measure 
with poor agreement with certain measures of similar constructs. Evidence for cross-cultural 
validity was poor, with only a forward translation carried out. 
Discussion 
Although research shows high rates of suicidality (Cassidy et al. 2014) and death by suicide in 
autistic adults (Hirvikoski et al. 2016), it was unknown whether any suicidality assessment 
tools had been used or validated in this group, or whether a robust tool developed for the 
general population needed to be adapted. Results from this review show that despite 
studies having explored suicidality in autistic adults without ID, no research has yet used a 
validated suicidality assessment tool in this group. This is consistent with the growing body 
of COSMIN reviews showing a paucity of validated outcome measures for autistic people 
(Cassidy et al. 2018; Hanratty et al. 2015; Wigham and McConachie, 2014). These results are 
an important call to action for the research community, to improve the characterisation of 
outcomes and their measurement in ASC, in research and clinical practice. 
 Studies of suicidality in ASC were found to utilise a question generated for use in the 
specific study, without evidence of validity, or used a single question or brief subscale from a 
broader mental health measure (e.g. PHQ-9, BDI, MINI, SCID). This may reflect the fact that 
currently many studies of suicidality in ASC have utilised convenience samples from clinical 
settings, wider studies and existing databases. This lack of standardised and in depth 
assessment is problematic. For example, single questions from depression measures such as 
the PHQ-9 do not distinguish self-harm from suicidal intent, and therefore do not assess 
suicidality per se. The range of measures, many of which lack evidence of validity, could also 
explain, at least in part, the wide range of suicidality estimates cited in recent reviews of 
suicidal ideation (11-66%) and attempts (1-35%) in ASC (Hedley and Uljarevic, 2018). A clear 
recommendation for future suicidality in ASC research is to start using suicidality assessment 
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tools with high quality evidence in support of their measurement properties, in line with the 
recommendations of COSMIN (Mokkink et al. 2016). We make recommendations on future 
selection of such tools based on our synthesis of the available evidence below.  
A number of validated suicidality assessment tools have been used frequently in 
studies of general population adults, without ID or co-occurring conditions; the SBQ-R, C-
SSRS, BSS, Paykel and SITBI. Interestingly, no studies were revealed from the comprehensive 
search that had assessed the measurement properties of the Paykel, despite it being utilised 
in a number of research studies. The C-SSRS and BSS had also been validated mainly in 
psychiatric samples despite being used in a number of general population studies. 
Importantly, although the evidence for hypothesis testing and criterion validity was mixed 
for the BSS, this clearly depended on the context in which this tool was used. Specifically, 
the BSS had strong evidence in support of distinguishing sub-groups (e.g. those who have 
and have not attempted suicide), but strong evidence against predicting future adverse 
events (e.g. hospital admissions for suicide attempt). The BSS also had strong evidence for 
internal consistency, structural validity, and moderate evidence for cross-cultural validity. 
Hence, the strengths of the BSS lie in distinguishing sub groups in research, but not when 
predicting future adverse events in clinical practice. 
Two versions of the C-SSRS were assessed; the self-report and clinician interview 
versions. The self-report version has been more recently developed, and therefore fewer 
studies (4) were available assessing its measurement properties than the clinician interview 
version (7). For the self-report C-SSRS, there was weak evidence against hypothesis testing, 
and mixed evidence for criterion validity. Specifically, there was moderate evidence in 
support of agreement between the C-SSRS self-report and clinician assessment (Yiguerta et 
al. 2015), but moderate evidence against the C-SSRS self-report predicting future adverse 
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events (Chang and Tan, 2015).  Currently, there is not yet enough evidence to recommend 
this tool for use in research or clinical practice.  
However, the clinician interview version of the C-SSRS had evidence in support of a 
number of measurement properties. The strengths of the measure lie in structural validity, 
hypothesis testing, criterion validity and responsiveness to change, and weak evidence in 
support of cross-cultural validity. Importantly, there was moderate evidence in support of 
the C-SSRS predicting future suicidal behaviour within 6 months of discharge (Madan et al. 
2016). There was however mixed evidence for internal consistency and reliability. This 
suggests that the clinician interview version of the C-SSRS is likely to be most useful in 
clinical contexts, to aid clinicians in helping to gauge potential suicide risk as part of a holistic 
psychosocial assessment, and changes in response to treatment or within clinical trials. 
However, more research is needed to establish evidence in support of inter-rater 
agreement, and internal consistency, particularly concerning subscales.  
There was only one study that had explored the measurement properties of the  
SITBI in adults without ID (with one additional validation study in an adolescent sample 
which was not included) (Garcia-Nieto et al. 2013). Hence there was limited evidence in 
support of its measurement properties. Notably, the study showed evidence against 
hypothesis testing with low agreement with measures of similar constructs. Future research 
needs to establish the measurement properties of this tool. 
 There were only two studies exploring the measurement properties of the SBQ-R, 
despite being used in a number of general population studies of suicidality. Despite this, 
there was strong evidence in support of internal consistency and structural validity, 
moderate evidence in support of criterion validity, and weak evidence in support of 
hypothesis testing. In particular, the SBQ-R showed evidence for high sensitivity and 
specificity for distinguishing sub-groups using the first item (Aloba et al. 2017) and total 
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scores (Osman et al. 2001; Aloba et al. 2017). Notably, the SBQ-R is the briefest tool out 
those identified in this review (with 1-4 items), does not carry a cost to use, and has 
comparable quality of evidence in support of a range of measurement properties compared 
to the other scales which are longer and carry a cost (C-SSRS and BSS). Hence, the SBQ-R 
could be particularly useful for future research. 
 In summary, the current study revealed strong consistent evidence across three 
frequently used suicidality assessment tools (BSS, C-SSRS and SBQ-R), for reliably 
distinguishing sub-groups (e.g. those who have or have not attempted suicide in the past). 
However, there were relatively few studies exploring an important component of criterion 
validity for suicidality assessment tools – prediction of future adverse events (e.g. future 
suicidal behaviour, future hospitalisations or emergency department visits). Research has 
suggested that suicidality assessment tools on the whole are poor predictors of future 
attempts, many perform worse than patient or clinical assessment, and may therefore be a 
waste of valuable resources (Quinlivan et al. 2017; Quinlivan et al. 2016). The current study 
adds useful evidence to this debate, as it is the first to use a validated research tool 
(COSMIN), to synthesise the quality of the evidence for a range of measurement properties, 
across a number of studies. On the basis of our synthesis of the available evidence, results 
suggest that certain tools (i.e. C-SSRS interview) may have greater utility in predicting future 
adverse events than others (e.g. BSS). Results also suggest that designs which assess 
criterion validity on the basis of distinguishing sub-groups may over-estimate diagnostic 
accuracy of a tool. This is consistent with previous research (Lijmer et al. 1999), which 
recommends the use of cohort studies in assessing the usefulness of suicidality assessment 
tools.  
Future Research 
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No studies have yet utilised any of the suicidality assessment tools that have been 
developed for and widely used in the general population, in autistic adults. As discussed 
above, the characteristics of ASC, and differing presentation of suicidality in this group, could 
all affect the utility of these tools. A first step would be to explore the content validity of 
these existing tools through focus groups and cognitive interviews, to inform adaptations, 
prior to exploring other measurement properties of these tools. COSMIN criteria stipulates 
that excellent studies should compare the performance of adapted to original measures 
(Mokkink et al. 2016). We also recommend comparing the performance of measures 
between ASC and general population groups, to ascertain whether measurement properties 
of tools are similarly robust in autistic and non-autistic populations. For example, if a 
measure designed for the general population does not adequately capture a health outcome 
in ASC, then we would expect a different factor structure, lower internal consistency, and 
criterion validity compared to the general population, which should then improve for the 
adapted version (see Cassidy et al. 2018).  
 Out of the tools identified and evaluated in this review, the SBQ-R is a free brief 
measure with only 4 questions, with comparable evidence in support of a range of 
psychometric measures compared to longer and more expensive tools (BSS and C-SSRS). It is 
therefore a promising potential candidate tool to begin exploring suicidality in ASC in 
research now, as an important stop gap before validated tools become available. Items one 
and two of the SBQ-R focus on suicidal thoughts and behaviours over one’s lifetime and in 
the past year, with clear definitions, e.g. “rarely (1 time)”. This could be potentially useful for 
assessing presence of suicidal thoughts and behaviours in autistic adults. However, items 
three and four will likely require adaptations for autistic adults which importantly provide 
more information on risk level. For example, autistic people’s communication difficulties 
may mean they are less likely to have had spontaneously communicated their suicidal intent 
to others in the past (item three), despite high risk. Additionally, literal interpretation and 
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difficulties in imagination and abstract future thinking in ASC may lead to difficulties 
interpreting and responding to the final question (item four) about likelihood of attempting 
suicide in the future. 
A crucial aspect of exploring validity of suicidality assessment tools, are whether 
these are useful to clinicians in gauging risk of future suicide attempts. However, few studies 
have explored this crucial aspect of criterion validity. Hence, it is critical that future studies 
assessing criterion validity of suicidality assessment tools in autistic and general populations 
not only rely on distinguishing sub-groups, which over-estimate diagnostic accuracy of a 
tool. Rather, cohort studies are needed to assess whether current and adapted suicidality 
assessment tools can predict future suicidal behaviour significantly more accurately than 
clinician opinion or patient self-report. 
Strengths and Limitations 
A key strength was using a rigorous method (COSMIN) to systematically identify and 
evaluate relevant studies. However, following this strict method meant that some tools were 
excluded from the analysis, such as single items or subscales from broader mental health 
measures. As suicidality in ASC is such a new area of research, it could be argued that 
adopting such rigorous methods might have led us to overlook other relevant data which 
could indicate the usefulness of one tool over another. However, we were interested in 
more specific and broader conceptualisations of suicidality than is feasible in single 
questions or subscales. We also focused on tools which had been used frequently in general 
population adults, without ID, or co-occurring conditions, rather than including measures 
only used in psychiatric groups, as these tools were more likely to be useful for a range of 
non-clinical and clinical groups, and in a range of clinical and research contexts. Our search 
was also limited by focusing only on studies in English, due to lack of translation resources, 
and data extraction was also conducted only in part by two independent reviewers. 
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Although COSMIN is a validated research tool, there is a certain level of subjectivity in rating 
each article. However, there was good agreement between raters in the current study 
(73%), similar to previous COSMIN reviews (e.g. Cassidy et al. 2018; Wigham and 
McConachie, 2014). 
Conclusion 
This is the first systematic review to use a robust research tool (COSMIN) to synthesise the 
evidence regarding the assessment of suicidality in autistic and general population adults 
without ID. Although a growing number of studies are beginning to assess suicidality in 
autistic adults, none have yet used a validated suicidality assessment tool, and there are 
currently no validated suicidality assessment tools available for this group. Three robust 
suicidality assessment tools were identified which have been used frequently in general 
population studies. Future ASC studies must begin to use and explore the measurement 
properties of such robust tools designed for the general population. Our research group are 
currently undertaking this research in order to better characterise suicidality and its 
measurement in ASC. 
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Tables: 
Table 1: Stage 1 review search terms. 
1. (general population or population sample or community sample or national* 
survey or household* survey or non referred or non clinical or population screen*) 
2. (ASC or ASD or Asperg* or Autis* or high functioning or pervasive developmental 
disorder* or PDD or HFA) 
3. (adult*) 
4. (assess* or tool or treatment outcome or measur* or scale or quotient or 
inventory or instrument) 
5. (suicid* or self harm or self inj* or parasuicide or suicide attempts or attempted 
suicide) 
6. randomised controlled trial or randomized controlled trial 
7. random* 
8. comparative stud* 
9. prospective stud* 
10. intervention 
11. treatment effectiveness evaluation or treatment response or treatment study 
12. epidemiolog* 
13. prevalence 
14. General Population Search (6 or 7 or 8 or 9 or 10 or 11 or 12 or 13) and (1 and 3 
and 4 and 5) 
15. Autism Spectrum Condition Search (6 or 7 or 8 or 9 or 10 or 11 or 12 or 13) and 
(2 and 3 and 4 and 5) 
16. limit 14 and 15 to English Language; 1992 – current; age 18 years + 
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Table 2: Methodological quality of studies included in the qualitative synthesis. 
Tool Article 
Internal 
consistency Reliability 
Measurement 
error 
Content 
validity  
Structural 
validity 
Hypothesis 
testing 
Cross-
cultural 
validity 
Criterion 
validity Responsiveness 
SBQ-R 
Osman et 
al. (2001). poor     fair  fair  
SBQ-R 
Aloba et al. 
(2017). excellent    excellent   good  
BSS 
De Beurs 
Fokkema 
and 
O’Connor 
(2016).      fair  excellent  
BSS 
Esfahani, 
Hashemi 
and Alavi 
(2015). excellent    good fair fair   
BSS 
Chang and 
Tan (2015).        good  
BSS 
Steer et al. 
    good     
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(1993). 
BSS 
De Beurs et 
al. (2015).     excellent good    
BSS 
Ayuh 
(2008). fair    fair  fair   
BSS 
Horon et al. 
(2012).      good  good  
BSS 
Chioqueta 
and Stile 
(2006). poor     fair poor   
BSS 
Healy et al. 
(2006).  poor    good    
BSS 
Holden and 
DeLisle 
(2005).     good     
BSS 
Pinninti et 
al. (2002). poor poor    fair  good  
BSS 
Cochrane-
Brink et al. 
(2000).      poor  poor  
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BSS 
Kliem et al. 
(2017). poor     fair    
C-SSRS 
(self-
report 
electroni
c version) 
Mundt et 
al. (2013).        good  
C-SSRS 
(self-
report) 
Viguera et 
al (2015).        good  
C-SSRS 
(self-
report) 
Sheehan et 
al. (2014).      fair  fair  
C-SSRS 
(self-
report) 
Chang and 
Tan (2015).        good  
C-SSRS 
(intervie
w) 
Madan et 
al. (2016). good    good fair  good  
C-SSRS 
(intervie
w) 
Al-Halabi et 
al. (2016). good    good fair fair  fair 
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C-SSRS 
(intervie
w) 
Youngstro
m et al. 
(2015). poor fair    fair  good  
C-SSRS 
(intervie
w) 
Horwitz, 
Czyz and 
King 
(2015).      good  good  
C-SSRS 
(intervie
w) 
Hesdorffer 
et al. 
(2013).  poor    fair    
C-SSRS 
(intervie
w) 
Mundt et 
al. (2010).  poor    poor    
C-SSRS 
(intervie
w) 
Posner et 
al. (2011). poor     fair  good fair 
SITBI 
Garcia-
Nieto et al. 
(2013).  Poor/fair    fair poor   
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Table 3: Collated evidence of measurement properties for each tool. 
Measure Version Measurement Properties Interpretability 
Internal 
Consistency 
Reliability Content 
Validity 
Structural 
Validity 
Hypothesis 
Testing 
Criterion 
Validity 
Responsiveness Cross-
cultural 
validity 
Differences in 
scores 
between 
groups 
SBQ-R V2 +++   +++ + 
 
++   Y 
BSS - +++* ?  +++ +/- +/-  ++ Y 
C-SSRS Self-
report 
    - +/-    
 Interview +/- +/-  +++ ++ +++ ++ +  
SITBI -  +/-   -   ?  
*denotes evidence from translated version only; ? indeterminant evidence for or against a measurement property; +/- mixed evidence for and against a 
measurement property; + consistent evidence in support of a measurement property (+ weak, ++ moderate, +++ strong evidence) evidence; - consistent 
evidence against a measurement property (- weak, -- moderate, --- strong evidence). 
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Appendices: 
Appendix A: Characteristics of suicidality tools identified in search one. 
Measure Version  Year 
published 
Aim of tool Number 
of items 
Subscales Response 
options (e.g. 4 
point scale, 
yes/no etc.) 
Format (e.g. 
self-report 
questionnaire, 
interview etc.) 
Used in which references?  
ASC Gen Pop 
Columbia 
Suicide 
Severity 
Rating Scale 
(C-SSRS) 
Interview  
 
 
 
Self-report 
2011 
 
 
 
2009 
Measure of suicide 
risk in research and 
clinical practise. 
6 
 
 
 
6 
N/A Yes/No 
 
 
 
Yes/No 
Clinician 
administered 
interview 
 
Self-report 
questionnaire 
N/A DeVyldet al (2015) 
 
 
 
Childress et al. (2010) 
Measure of 
episodic 
planning of 
suicide 
(MEPOS) 
V1 2014 Assesses frequency 
and characteristics 
of prior suicide 
attempts 
4 N/A Yes/No and 
single 
response 
follow up 
questions 
Self-report 
questionnaire 
N/A Anestis et al. (2014) 
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Suicide 
Behaviours 
Questionnaire 
Revised (SBQ-
R) 
V2 2001 Measure of suicide 
risk 
4 N/A  5/6 point 
scales 
Self-report 
questionnaire 
N/A Campose and Holden 
(2014); Campos, 
Besser and Blatt 
(2013); Wagner et al. 
(2013). 
Beck Scale for 
Suicidal 
Ideation (BSS) 
V2 1991 Assesses suicidal 
ideation and 
behaviours 
21 1-19 current 
suicidal ideation, 
20-21 past suicide 
attempts 
Yes/No (check 
this!) 
Self-report 
questionnaire 
N/A Spiker et al. (2012);  
Van Orden et al. 
(2012); Cleary, Nixon 
and Fitzgerald, (2007); 
Lane, Cheref and 
Miranda (2016); 
Zuromski et al (2017). 
Beck Suicide 
Intent 
Inventory 
V1 1974 Assesses risk of 
suicidal attempts 
in patients who 
have attempted 
suicide 
15 1-8 objective 
circumstances 
surrounding suicide 
attempt, 9-15 self-
report questions 
surrounding suicide 
attempt 
Scale 1-3 
options 
Clinician 
administered 
and self-report 
questionnaire 
N/A Moran et al. (2012). 
Depression 
Severity Index 
– Suicide 
Subscale (DSI-
SS) 
V1 1997 Identify frequency 
and intensity of 
current suicidal 
ideation and 
impulses in the 
4 N/A Scale 1-4 
options 
Self-report 
questionnaire 
N/A Cukrowicz et al. 
(2009). 
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past 2 weeks 
Modified 
Scale for 
Suicidal 
Ideation 
(MSSI) 
V1 1986 Assess presence 
and severity of 
current suicidal 
ideation in the past 
2 weeks. 
18 N/A Scale 1-4 
options 
Self report 
questionnaire 
N/A Bagge et al. (2014). 
Paykel V1 1974 Assess lifetime and 
current experience 
of suicidal ideation 
and behaviours 
5 N/A Scale 1-4 Clinician 
administered 
interview or 
self-report 
questionnaire 
N/A Jonson et al (2012); 
Rancāns et al. (2003); 
Renberg, (2001). 
Sheehan 
Suicidality 
Tracking Scale 
(S-STS) 
V10 2009 Tracks 
spontaneous and 
treatment 
emergent suicidal 
ideation and 
behaviours 
8 Self-injury, self-
harm, suicidal 
ideation and 
suicide attempts. 
Yes/No or 
scale 1-4 
Clinician 
administered or 
self report 
rating scale 
N/A Preti et al. (2013). 
Suicide 
Assessment 
Scale (SUAS-S) 
V1 2006 Assesses signs and 
symptoms related 
to suicidality 
20 N/A Scale 0-4 Self report 
questionnaire 
N/A Zhang et al. (2012). 
Suicide 
Ideation Scale 
V1 1989 Measured a 
continuum of 
suicidal thoughts 
10 N/A Scale 1-5 Self report 
questionnaire 
N/A Chu et al. (2008). 
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(SIS) and attempts in 
clinical and non 
clinical samples 
Suicide Score 
Scale (SSS) 
V1 2008 Designed to obtain 
information about 
life time and past 
year previous 
suicidal ideation, 
planning or 
attempts 
12 N/A Yes/No Self report 
questionnaire 
N/A Innamorati et al. 
(2008). 
Self-Injurious 
Thoughts and 
Behaviours 
Interview 
(SITBI) 
V1 2007 A structured 
interview that 
assesses the 
presence, 
frequency, and 
characteristics of a 
wide range of self-
injurious thoughts 
and behaviours, 
including suicidal 
ideation, suicide 
plans, suicide 
gestures, suicide 
attempts, and non-
suicidal self-injury 
169 
items 
across 5 
modules 
5 subscales: (a) 
suicidal ideation; 
(b) suicide plans; 
(c) suicide gestures; 
(d) suicide 
attempts; and (e) 
non-suicidal self- 
injury. 
Yes/No and 
scales 1-4 
Interview N/A Dhingra, Boduszek and 
Klonsky (2016); 
Mortier et al. (2017a); 
Mortier et al. (2017b). 
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(NSSI). 
Plutchik 
Suicide Risk 
Scale (PSRS) 
V1 1989 Measures the 
degree to which an 
individual reveals 
characteristics 
similar to those of 
a suicide 
prototype. 
26 items N/A Yes/No Self-report N/A Pereira-Morales et al. 
(2017). 
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Appendix B: Characteristics of study populations included in the qualitative synthesis. 
Measure Article Study population/ 
sample 
Study type 
(prospective, 
case-control etc.) 
Mean age (SD) 
years; range 
Total N Male n, 
female n. 
Country 
SBQ-R Osman et al. 
(2001). 
Psychiatric patients 
 
 
High school 
adolescent 
 
 
Psychiatric patients 
 
 
 
Undergraduate 
Psychology student 
Case-control 15.63/15.56 
(0.98) 14-17 
years 
 
16.51/16.47 
(1.33/1.14) 14-
18 years 
 
32.14/33.47 
(7.43/8.79) 
age range not 
reported 
 
21.19/20.97 
(2.98/2.91) 
age range not 
120 
 
 
 
138 
 
 
120 
 
 
 
135 
65 male, 55 
female 
 
 
72 male, 66 
female 
 
 
65 male, 55 
female 
 
 
69 male, 66 
female 
US 
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reported 
SBQ-R Aloba et al. 
(2017). 
Adult undergraduate 
students 
Cross-sectional 22.51 (2.94) 
18–31 years 
536 272 
(50.7%) 
male, 263 
(49.3%) 
female 
Nigeria 
BSS De Beurs 
Fokkema and 
O’Connor 
(2016). 
Psychiatric patients Longitudinal 33/38 
(13.2/13.8) 
age range not 
provided 
366 158 male, 
208 female 
UK 
BSS Esfahani, 
Hashemi and 
Alavi (2015). 
General population  Cross-sectional 27 (9.5)18-70 
years 
535 138 male, 
397 female 
Tehran 
BSS / C-SSRS 
(self report) 
Chang and Tan 
(2015). 
Psychiatric patients Prospective 36.4 age range 
20-47 years 
50 22 male, 28 
female 
US 
 
BSS De Beurs et al. 
(2015). 
Psychiatric patients Longitudinal 43 (15) age 
range not 
provided 
872 (at 
baseline) 
415 male, 
457 female 
Netherlands 
BSS Horon et al. 
(2013). 
Psychiatric Patients Cross- sectional 37, age range 
19-75 
342 342 male US 
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BSS Ayub (2008). General population 
adolescents and young 
adults 
Cross-sectional 20.06, (2.39) 
17-25 years. 
904 442 female Pakistan 
BSS Chioqueta and 
Stiles (2006). 
University students Cross-sectional 21.46 (3.63) 
17-44 years. 
314 71 male, 
243 female 
Norway 
BSS Healy et al. 
(2006) 
Psychiatric patients Cross-sectional 37.51 (13.52), 
18-37 years. 
735 319 male, 
413 female 
US 
BSS Holden and 
DeLisle (2005). 
Psychology students 
and community 
sample suicide 
attempters 
Cross-sectional 24.39 (11.47), 
17-68 years. 
134 15 male, 
119 female 
Canada 
BSS Pinninti et al 
(2002). 
Psychiatric patients Cross-sectional 41.68 (4.91), 
age 18+ 
130 64 male, 66 
female 
US 
BSS Cochrane-
Brink et al 
(2000). 
Psychiatric patients Cross-sectional 34.7 (10.9), 
age 18+ 
55 31 male, 24 
female 
Canada 
BSS Steer et al. 
(1993). 
Psychiatric patients Cross-sectional 38.28 (14.14), 
age range not 
provided 
330 154 male, 
176 female 
US 
BSS Kliem et al. 
(2017). 
General population 
adults identified as 
high suicide risk on 
Cross-sectional 49.7 (17.83), 
age 18+ 
112 53% male Germany 
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BSS 
C-SSRS Madan et al. 
(2016). 
Inpatient cohort of 
mentally ill adults 
Prospective 35.2 (+/- 14.7 
years) 
1055 540 male, 
515 female 
US 
C-SSRS Al-Halabi et al. 
(2016). 
Psychiatric patients Cross-sectional 46.93 467 Not 
specified 
Spain 
C-SSRS Youngstrom et 
al. (2015). 
Adult inpatients Cross-sectional 38.5 (+/- 12.4 
years) 
199 57% female US 
C-SSRS Viguera et al. 
(2015). 
Psychiatric patients Cross-sectional 43.7 (+/- 14.9 
years), age 
range 18-94 
years 
1416 533 male, 
883 female 
US 
C-SSRS Sheehan et al. 
(2014). 
Adults with self-
injurious behaviour 
Cross sectional 39.9 (15), age 
range 19-73 
years 
40 44.4% male US 
C-SSRS Horwitz, Czyz 
and King 
(2015). 
Psychiatric patients Longitudinal 19.38 (2.9), 
age range 15-
24 years. 
473 220 male, 
253 female 
US 
C-SSRS Mundt et al. 
(2013). 
Clinical samples from 
treatment trials 
Prospective Not reported 3776 Not 
reported 
US 
C-SSRS Hesdorffer et Treatment resistant Cross-sectional 41.2 (31.2), 
age range 18-
208 71 male, US 
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al. (2013). focal epilepsy 70 years 137 female 
C-SSRS Mundt et al. 
(2010). 
Psychiatric patients 
 
 
General population 
controls 
Case-control 30.9 years, age 
range 18-57 
years 
 
32.9 year, age 
range 24-40 
years 
10 
 
 
 
10 
4 male, 6 
female 
 
 
1 male, 9 
female 
US 
C-SSRS Posner et al. 
(2011). 
Adolescent suicide 
attempters 
 
Depressed 
adolescents 
 
 
Psychiatric patients 
Treatment study 
 
 
Medication 
efficacy trial – 
longitudinal 
 
Cross sectional 
study 
12-18 years 
 
 
11-17 years 
 
 
Over 18 years 
124 
 
 
312 
 
 
237 
 US 
SITBI Garcia-Nieto et 
al. (2013). 
Psychiatric patients Cross sectional 43.3 years 
(10.3), no age 
150 84 (56) 
female 
Spain 
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range given 
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